BLOG > Publications & Citations > Distinct antigen presentation drives potent T cell immunity in mRNA-LNP vaccines
Authors: Ryunosuke Muro et al.
Source: Sci. Adv.12,eaec7827(2026)
We're delighted to share insights from a recent study entitled "A distinct antigen presentation pathway drives potent T cell immunity in lipid nanoparticle–based mRNA vaccines" published in Science Advances by Ryunosuke Muro et al.
They identified an unconventional antigen presentation pathway driven by migratory type 2 conventional dendritic cells (cDC2) that triggers exceptionally strong and durable T cell responses. This research explains why mRNA-LNP formulations are so effective compared to traditional adjuvants, revealing that they don't even require the traditional cross-presentation pathway to achieve superior immunity.
Congratulations to all the authors on this excellent article!
Our modified mRNA was used to encode the model antigens (OVA and GFP) necessary to track and measure these potent immune responses with high precision.
Related publications
Transdermal Delivery of an mRNA-Liposome Vaccine via Dissolving Microneedle
RNA innate immunity constitutes a barrier for interspecies chimerism
